<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="research-article" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">KJIM</journal-id>
<journal-title-group>
<journal-title>The Korean Journal of Internal Medicine</journal-title></journal-title-group>
<issn pub-type="ppub">1226-3303</issn>
<issn pub-type="epub">2005-6648</issn>
<publisher>
<publisher-name>Korean Association of Internal Medicine</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3904/kjim.1987.2.1.18</article-id>
<article-id pub-id-type="publisher-id">kjim-2-1-18-3</article-id>
<article-categories>
<subj-group>
<subject>Original Article</subject></subj-group></article-categories>
<title-group>
<article-title>Insulin Binding and its Action in Adipocytes of Hyperthyroid and Hypothyroid Rats<xref ref-type="fn" rid="fn1-kjim-2-1-18-3"><sup>&#x0002A;</sup></xref></article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Kim</surname><given-names>Young Woo</given-names></name>
<degrees>M.D.</degrees></contrib>
<contrib contrib-type="author">
<name><surname>Son</surname><given-names>Ho Young</given-names></name>
<degrees>M.D.</degrees><xref ref-type="corresp" rid="c1-kjim-2-1-18-3"/></contrib>
<contrib contrib-type="author">
<name><surname>Min</surname><given-names>Byong Sok</given-names></name>
<degrees>M.D.</degrees></contrib>
<contrib contrib-type="author">
<name><surname>Kim</surname><given-names>Hak Joong</given-names></name>
<degrees>M.D.</degrees></contrib>
<aff id="af1-kjim-2-1-18-3">Department of Internal Medicine, Catholic Medical College, Seoul, Korea</aff></contrib-group>
<author-notes>
<corresp id="c1-kjim-2-1-18-3">Address reprint requests: Ho Young Son, M.D., Department of Internal Medicine, Catholic Medical College, &#x00023; 505, Banpodong, Kang Nam Gu, Seoul 135, Korea.</corresp><fn fn-type="supported-by" id="fn1-kjim-2-1-18-3">
<label>&#x0002A;</label>
<p>This work was supported by Catholic Medical Center Clinical Research Funds</p></fn></author-notes>
<pub-date pub-type="ppub">
<month>1</month>
<year>1987</year></pub-date>
<volume>2</volume>
<issue>1</issue>
<fpage>18</fpage>
<lpage>25</lpage>
<permissions>
<copyright-statement>Copyright &#x000A9; 1987 The Korean Association of Internal Medicine</copyright-statement>
<copyright-year>1987</copyright-year>
<license>
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions>
<abstract>
<p>The studies of the effects of thyroid hormone on insulin secretion and glucose metabolism have been made, but the results have been controversial.</p>
<p>In order to evaluate the effects of thyroid hormone at the cellular level, insulin binding and insulin-induced lipogenesis in isolated rat epididymal fat cells were studied in control, hyperthyroid and hypothyroid rats. Hyperthyroidism was induced by daily intraperitoneal injection of sodium L-thyroxine and hypothyroidism by a single injection of <sup>131</sup>I. The adipocytes were isolated by treatment of collagenase as originally described by Gliemann (1967).</p>
<p>The results were as follows:
<list list-type="simple">
<list-item>
<p>1) The fasting serum insulin levels of hyperthyroid (21.6 &#x000B1; 3.7 uU/ml) and hypothyroid groups (20.5 &#x000B1; 7.0 uU/ml) were not different from the value of control (23.1 &#x000B1; 11 uU/ml). The fasting blood glucose level of hypothyroid group (164.9 &#x000B1; 12.0 mg/dl) was higher than the values of the controls (148.2 &#x000B1; 13.2 mg/dl) or the hyperthyroid group (147.0 &#x000B1; 12.5 mg/dl), (p&#x0003C;.005).</p></list-item>
<list-item>
<p>2) The specific <sup>125</sup>I-insulin binding of the hyperthyroid group was not different from the value of the controls, but the value of the hypothyroid group was higher than the value of the controls (p&#x0003C;.005).</p></list-item>
<list-item>
<p>3) The insulin receptor concentration of the hypothyroid group (1.09 &#x000B1; 0.02 ng/0.5&#x000D7;10<sup>5</sup> cells) was higher than the value of the controls (0.72 &#x000B1; 0.01 ng/0.5&#x000D7;10<sup>5</sup> cells) or the hyperthyroid group (0.79 &#x000B1; 0.02 ng/0.5&#x000D7;10<sup>5</sup> cells), (p&#x0003C;.05).</p></list-item>
<list-item>
<p>4) The average affinities of the receptors in all groups showed an inverse correlation with the insulin concentration. The average affinity of the hypothyroid group was higher than the value of the control or the hyperthyroid group.</p></list-item>
<list-item>
<p>5) Insulin-induced lipogenesis was reduced proportionately in all insulin concentrations in both the hyperthyroid and hypothyroid groups compared with the dose-response curve of the control group. The maximal amount of lipogenesis of the hyperthyroid and hypothyroid groups were 63.4&#x00025; (p&#x0003C;.05) and 32.3&#x00025; (p&#x0003C;.005) of the controls, respectively.</p></list-item></list></p>
<p>These studies suggest that thyroid hormone may regulate the concentration of insulin receptors, and altered thyroid states reduce insulin-induced lipogenesis in the adipocyte at postreceptor levels.</p></abstract>
<kwd-group>
<kwd>Insulin binding</kwd>
<kwd>Insulin-induced lipogenesis</kwd>
<kwd>Insulin receptor concentration</kwd>
<kwd>Postreceptor</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>INTRODUCTION</title>
<p>Glucose intolerance is frequently observed in hyperthyroidism and, the development of hyperthyroidism in diabetic patients is often accompanied by a further deterioration of glucose control. These findings suggested that thyroid hormones may affect the secretion or action of insulin. But it is not known whether the underlying mechanisms are due to a defect in insulin secretion or insulin action.</p>
<p>Studies of the effects of thyroid hormones on insulin secretion have yielded conflicting results. Thus, it has been reported that insulin secretion is decreased<sup><xref ref-type="bibr" rid="b1-kjim-2-1-18-3">1)</xref></sup> or increased<sup><xref ref-type="bibr" rid="b2-kjim-2-1-18-3">2)</xref></sup> in hyperthyroidism and decreased<sup><xref ref-type="bibr" rid="b3-kjim-2-1-18-3">3)</xref></sup> in hypothyroidism.</p>
<p>Accordingly, mechanisms of the influence of thyroid hormones on insulin secretion still remain controversial. However, Andersen et al<sup><xref ref-type="bibr" rid="b4-kjim-2-1-18-3">4)</xref></sup> observed the increased level of plasma glucose concomittant with an increased insulin secretion in hyperthyroidism, and suggested that thyroid hormones developed a decreased insulin sensitivity at the target tissue level.</p>
<p>Arner et al.<sup><xref ref-type="bibr" rid="b34-kjim-2-1-18-3">34)</xref></sup> also suggested that thyroid hormones regulate the effect of insulin action, which occurs at receptor and post-receptor levels in the target tissue. In the present study, the authors examined the mechanism of the effect of thyroid hormones on insulin action at target tissue levels, using isolated fat cells from experimentally induced hyperthyroid and hypothyroid rats.</p>
<p>The binding of insulin to isolated fat cells and the effect of insulin on fat cell lipogenesis were determined.</p></sec>
<sec sec-type="materials|methods">
<title>MATERIALS AND METHODS</title>
<p>(<sup>125</sup>I)-monoiodinated insulin (S.A. 250 uCi/ug) was purchased from New England Nuclear Co. (Boston, Mass). Porcine monocomponent insulin was obtained from Novo Ind. (Denmark). D-glucose, bovine serum albumin (fraction V) and collagenase (type II) were purchased from Sigma Chemical Co. (St. Louis, Mo.). D-(3-<sup>3</sup>H) glucose (S. A. 5.3 Ci/mmol) was purchased from Radiochemical Centre (Amersham, England).</p>
<sec>
<label>1.</label>
<title>Animals</title>
<p>Male Wister rats Weighting 100&#x02013;150 gm were used.</p>
<p>In order to induce hyperthyroid rats, sodium L-thyroxine (50 ug per 100 gm body Weight) disolved in 0.1 N NaOH and 2&#x00025; human albumin was injected into the peritoneum for 7 days as described by Laker and Mayes<sup><xref ref-type="bibr" rid="b10-kjim-2-1-18-3">10)</xref></sup> and to induce hypothyroid rats, <sup>131</sup>I (0.4 mCi per 100 gm body Weight) was injected into the peritoneum 3 weeks prior to use as described by Ahren and Lundquist<sup><xref ref-type="bibr" rid="b11-kjim-2-1-18-3">11)</xref></sup></p></sec>
<sec>
<label>2.</label>
<title>Adipocytes Isolation</title>
<p>Isolated fat cells were prepared as described by Rodbell<sup><xref ref-type="bibr" rid="b12-kjim-2-1-18-3">12)</xref></sup> and modified by Gliemann<sup><xref ref-type="bibr" rid="b13-kjim-2-1-18-3">13)</xref></sup>. Briefly, the epididymal fat pads from each rat were incubated in vials containing collagenase, bovine serum albumin (30 g/l) and D-glucose (0.05 mmol/l) in a Krebs-Ringer bicarbonate buffer solution. The air in the vials was displaced with oxygen-carbon dioxide (95.5&#x00025;) and the vials incubated in a metabolic shaker at 37&#x000B0;C for 90 minutes. The suspension was filtered through nylon mesh. The fat cells were left to float to the surface and the infranatant was aspirated and replaced with buffer. The number of fat cells was determined by counting the cells in a hemocytometer.</p></sec>
<sec>
<label>3.</label>
<title>Insulin Binding</title>
<p>Isolated fat cells suspended in a Tris buffer containing bovine serum albumin (30g/1) were incubated with <sup>125</sup>I-insulin(0.2 ng/ml) and various concentrations of unlabeled insulin in plastic vials in a shaking water bath for 90 minutes at 37&#x000B0;C. The incubations were terminated by removing aliquots (200 ul) from the cell suspension and rapidly centrifuging the cells in plastic microtubes to which 100 ul of silicone oil had been added. Silicone oil has a specific gravity between that of buffer and cells; therefore after centrifugation, three layers result: cells on top, oil in the middle, and buffer on the bottom. The cells were then removed and the radioactivity was determined. In these experiments, nonspecific binding was defined as the amount of <sup>125</sup>I-insulin remaining in the cell layer in the presence of a large excess (2 &#x000D7; 10<sup>3</sup> ng/ml) of unlabeled insulin.</p></sec>
<sec>
<label>4.</label>
<title>Lipogenesis</title>
<p>Lipogenesis from glucose was determined by the method of Moody et al.<sup><xref ref-type="bibr" rid="b14-kjim-2-1-18-3">14)</xref></sup>. After fat cells had been incubated in a shaking water bath at 37&#x000B0;C for 90 minutes in a 1 ml medium containing D-glucose (0.05 nmol/1), 3-(3H-glucose 0.1 uCi and various insulin concentrations (0&#x02013;380 ng/ml), (3H)-lipid was extracted into a toluene scintillant and counted by a Packard liquid scintillation spectrometer. Results were expressed as amounts of glucose (nmol) converted to toluene-extractable lipid in 90 minutes by 10<sup>5</sup> cells and plotted on the y-axis (<xref ref-type="fig" rid="f4-kjim-2-1-18-3">Fig. 4</xref>).</p></sec></sec>
<sec sec-type="results">
<title>RESULTS</title>
<sec>
<label>1.</label>
<title>Experimental Animals</title>
<p><xref ref-type="table" rid="t1-kjim-2-1-18-3">Table 1</xref>. Summarizes the characteristics of the control and the hyperthyroid and the hypothyroid rats. As can be seen, the serum T<sub>3</sub> and T<sub>4</sub> levels of the hypothyroid group were lower than the value of the control (p&#x0003C;.005). The serum T<sub>3</sub> and T<sub>4</sub>, levels of the hyperthyroid group were higher than the value of the control (p&#x0003C;.005).</p>
<p>However, the serum insulin levels of the hyperthyroid and hypothyroid group were not different from the values of the controls. The blood glucose level of the hypothyroid group was higher than the values of the control or the hyperthyroid group (p&#x0003C;.005).</p></sec>
<sec>
<label>2.</label>
<title>Insulin Binding</title>
<p>The competitive binding curves of <sup>125</sup>I-insulin and unlabelled insulin to adipocyte from the hyperthyroid, the hypothyroid, and the control are shown in <xref ref-type="fig" rid="f1-kjim-2-1-18-3">Fig. 1</xref>. The specific binding was taken as the difference between total and nonspecific binding. The specific <sup>125</sup>I-insulin binding for all groups correlated negatively with the insulin concentration. The maximum specific insulin binding for the control, the hyperthyroid, and the hypothyroid group was 1.36 &#x000B1; 0.07, 1.37 &#x000B1; 0.08, and 1.42 &#x000B1; 0.34 &#x00025;, respectively (<xref ref-type="table" rid="t2-kjim-2-1-18-3">Table 2</xref>).</p>
<p>Scatchard plots<sup><xref ref-type="bibr" rid="b15-kjim-2-1-18-3">15)</xref></sup> of the data yielded the curvilinear plots characteristic of insulin binding (<xref ref-type="fig" rid="f2-kjim-2-1-18-3">Fig. 2</xref>), at each insulin receptor concentration.</p>
<p>Insulin receptor concentration per cell of the control, the hyperthyroid, and the hypothyroid group were 0.72 &#x000B1; 0.01 ng/0.5 &#x000D7; 10<sup>5</sup> cells, 0.79 &#x000B1; 0.02ng/10<sup>5</sup> cells and. 1.09 &#x000B1; 0.02 ng/0.5 &#x000D7; 10<sup>5</sup> cells, respectively (<xref ref-type="table" rid="t2-kjim-2-1-18-3">Table 2</xref>).</p>
<p>The average affinity profiles<sup><xref ref-type="bibr" rid="b16-kjim-2-1-18-3">16)</xref></sup> calculated from the Scatchard plots were higher in the hypothyroid group compared with those of the control and hyperthyroid group in high receptor occupancy sites (<xref ref-type="fig" rid="f3-kjim-2-1-18-3">Fig. 3</xref>). The average empty site (K&#x00304;e) and full site (K&#x00304;f) affinities calculated from the average affinity profiles were higher in the hypothyroid group (8.07 &#x000D7; 10<sup>7</sup>/M and 3.76 &#x000D7; 10<sup>7</sup>/M, respectively) compared with that of the control (8.09 &#x000B1; 10<sup>7</sup>/M and 2.74 &#x000B1; 10<sup>7</sup>/M, respectively), and that of the hyperthyroid group (7.11 &#x000D7; 10<sup>7</sup>/M and 2.55 &#x000D7; 10<sup>7</sup>/M) (<xref ref-type="table" rid="t2-kjim-2-1-18-3">Table 2</xref>).</p></sec>
<sec>
<label>3.</label>
<title>Lipogenesis</title>
<p>To analyze one major pathway of glucose metabolism in the postreceptor level, the rate of glucose conversion to triglyceride was measured at various concentrations of unlabelled insulin (0&#x02013;1,000 uU/ml) with adipocytes from the control, the hyperthyroid, and the hypothyroid rats. The lipogenesis was reduced, proportionately at all insulin concentrations in the hyperthyroid group versus the control group and more significantly reduced in the hypothyroid group. The insulin-induced lipogenesis increased proportionately as the insulin concentration increased and achieved maximal response at 160 uU/ml of insulin concentration (<xref ref-type="fig" rid="f4-kjim-2-1-18-3">Fig. 4</xref>). The maximal lipogenesis in adipocytes from the hypothyroid and the hyperthyroid group were 32.3&#x00025; (P&#x0003C;.05) and 63.4&#x00025; (P&#x0003C;.005) of that of the control value.</p></sec>
<sec sec-type="methods">
<label>4.</label>
<title>Analytical Procedures</title>
<p>Serum glucose was determined using a glucose oxidase method. Serum insulin and T3 and T4 were determined by radioimmunoassay kits (Cambridge; Medical Diagnostics, Inc. U.S.A. and Daiichi Radioisotope Labs. Ltd., respectively).</p>
<p>The values of insulin binding, and lipogenesis expressed as the mean&#x000B1;SD in 3 separate experiments performed on different days. Comparisons were made using the Student&#x02019;s t-test of statistical significance and differences accepted as significant at the P&#x0003C;.05 level. The cell suspension was diluted until it contained 0.5 &#x000D7; 10<sup>5</sup> cells per ml. the viability of fat cells was assessed by the trypan blue dye exclusion test.</p></sec></sec>
<sec sec-type="discussion">
<title>DISCUSSION</title>
<p>Thyroid hormones are known to influence carbohydrate metabolism, e.g., on glycolysis<sup><xref ref-type="bibr" rid="b17-kjim-2-1-18-3">17)</xref></sup> and gluconeogenesis<sup><xref ref-type="bibr" rid="b18-kjim-2-1-18-3">18)</xref></sup>. Hyperthyroidism in man is often associated with elevated plasma glucose concentration<sup><xref ref-type="bibr" rid="b17-kjim-2-1-18-3">17</xref>&#x02013;<xref ref-type="bibr" rid="b20-kjim-2-1-18-3">20)</xref></sup>. And also it is frequently observed that glucose control becomes worse in diabetic patients who develop hyperthyroidism. However, the mechanisms underlying this influence are not known.</p>
<p>It has been reported that thyroid hormones decrease insulin secretion<sup><xref ref-type="bibr" rid="b1-kjim-2-1-18-3">1)</xref></sup>. In vitro studies it has also been demonstrated that insulin secretion is decreased by stimulation of the B-adrenergic receptor or glucose in hyperthyroidism<sup><xref ref-type="bibr" rid="b2-kjim-2-1-18-3">2</xref>,<xref ref-type="bibr" rid="b21-kjim-2-1-18-3">21</xref>&#x02013;<xref ref-type="bibr" rid="b23-kjim-2-1-18-3">23)</xref></sup>. But, contradictory results have also been reported<sup><xref ref-type="bibr" rid="b3-kjim-2-1-18-3">3</xref>,<xref ref-type="bibr" rid="b4-kjim-2-1-18-3">4</xref>,<xref ref-type="bibr" rid="b24-kjim-2-1-18-3">24</xref>,<xref ref-type="bibr" rid="b25-kjim-2-1-18-3">25)</xref></sup>, and decreased insulin secretion has been reported in hypothyroidism as well<sup><xref ref-type="bibr" rid="b2-kjim-2-1-18-3">2)</xref></sup>. Accordingly, the influence of thyroid hormones on insulin secretion still remains controversial. However, recently it was suggested that thyroid hormones modify the effects of insulin action at the level of the target tissues<sup><xref ref-type="bibr" rid="b4-kjim-2-1-18-3">4</xref>,<xref ref-type="bibr" rid="b34-kjim-2-1-18-3">34)</xref></sup>.</p>
<p>The purpose of the present study was to elucidate the mechanism of the effects of thyroid hormones on insulin action at the target tissue. Using isolated fat cells from experimentally induced hyperthyroid and hypothyroid rats, we examined insulin binding, insulin receptor number, insulin affinity and insulin-induced lipogenesis in the fat cell.</p>
<p>Monocyte and erythrocyte have been useful tools in studies of the insulin receptor<sup><xref ref-type="bibr" rid="b26-kjim-2-1-18-3">26</xref>&#x02013;<xref ref-type="bibr" rid="b29-kjim-2-1-18-3">29)</xref></sup>. However, it is well known that these are not classic target tissue for insulin. Accordingly, in a further attempt to document the alteration of insulin action at the target tissue, we have used isolated fat cells in this study. It is generally accepted that the fat cell is a valuable tool to investigate insulin binding and the biological activity of insulin at the intracellular level<sup><xref ref-type="bibr" rid="b6-kjim-2-1-18-3">6</xref>,<xref ref-type="bibr" rid="b7-kjim-2-1-18-3">7</xref>,<xref ref-type="bibr" rid="b30-kjim-2-1-18-3">30</xref>&#x02013;<xref ref-type="bibr" rid="b33-kjim-2-1-18-3">33)</xref></sup>. However, there are only a few reports about insulin action on fat cells in thyroid dysfunction and the results are controversial.</p>
<p>In the present study, we observed a significant increase in insulin binding to isolated fat cells in the hypothyroid rats (<xref ref-type="fig" rid="f1-kjim-2-1-18-3">Fig. 1</xref>), and it was due to the increased insulin receptor number. But the value of insulin binding in hyperthyroid rats was not different from the value in control rats. These results are different from the recent report of Arner et al.<sup><xref ref-type="bibr" rid="b34-kjim-2-1-18-3">34)</xref></sup>. Who demonstrated decreased insulin binding and insulin receptor concentration in hyperthyroidism. With regard to the insulin receptor, there are different results: increased insulin receptors in hypothyroidism<sup><xref ref-type="bibr" rid="b36-kjim-2-1-18-3">36)</xref></sup>. It is postulated that such conflicting results may be due to the different methods and materials in each study. The insulin level was not changed in the hyperthyroid and hypothyroid rats in this study; accordingly, insulin can not be the cause of changes in insulin receptor number by the up or down regulation mechanism<sup><xref ref-type="bibr" rid="b37-kjim-2-1-18-3">37)</xref></sup>.</p>
<p>It is suggested that the thyroid hormone directly regulates the insulin receptor number, possibly by alteration of the synthesis or degradation of the receptor. But in the present study, we are not able to demonstrate the evidence that thyroid hormones can control the synthesis or degradation of the insulin receptor. However, this study showed increased insulin receptor number in hypothyroidism and no change of insulin receptor number in hyperthyroidism. This finding suggests that insulin receptor number may be affected by the concentration of thyroid hormones; further investigation on the relationship between the thyroid hormones and insulin receptor in the fat cell will be needed.</p>
<p>With regard to insulin-induced lipogenesis in the fat cell, we observed significantly decreased lipogenesis at all insulin concentrations used in the experiment in both the hyperthyroid and the hypothyroid rats. Laker and Mayes<sup><xref ref-type="bibr" rid="b10-kjim-2-1-18-3">10)</xref></sup> reported a decreased lipogenesis in the hypothyroid liver. This result is similar to ours, however, it is difficult to compare to our datas because Laker and Mayes did not perform an insulin receptor assay in hypothyroidism, and a lipogenesis study in hyperthyroidism.</p>
<p>Our data suggest that thyroid hormone may modify not only the insulin receptor number, but also the intracellular biologic action of insulin; and the existence of a receptor defect in both hyper- and hypothyroidism. The results lead to the conclusion that thyroid dysfunction affects the postreceptor pathway of glucose metabolism in fat cells. The mechanism of the effects of thyroid hormones on insulin-induced lipogenesis in fat cells cannot be demonstrated in this study. However, it could be suggested that thyroid hormones may influence the intracellular enzyme or enzymes for regulating lipogenesis in the fat cell by the mechanisms of synthesis or degradation and/or increase or decrease its activity. By this mechanism, the cause of decreased lipogenesis in hypothyroidism can be explained.</p>
<p>In a several previous investigations, it has been demonstrated that thyroid hormones modulate the activity of cyclic AMP, phosphodiesterase<sup><xref ref-type="bibr" rid="b38-kjim-2-1-18-3">38)</xref></sup>, adenylate cyclase<sup><xref ref-type="bibr" rid="b39-kjim-2-1-18-3">39)</xref></sup> in fat cells, and the enzymes related to carbohydrate metabolism in hepatocytes<sup><xref ref-type="bibr" rid="b18-kjim-2-1-18-3">18)</xref></sup>. Thus, further evaluations of the enzyme or enzymes which relate to carbohydrate metabolism will be needed to confirm the mechanism of our results.</p>
<p>In summary, the present studies demonstrated that thyroid hormones may regulate the concentration of insulin receptor, and that thyroid dysfunction reduces insulin induced lipogenesis at the postreceptor level in fat cells.</p></sec></body>
<back>
<ref-list>
<title>REFERENCES</title>
<ref id="b1-kjim-2-1-18-3"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenzen</surname><given-names>S</given-names></name><name><surname>Joost</surname><given-names>HG</given-names></name><name><surname>Hasselblatt</surname><given-names>A</given-names></name></person-group><article-title>Thyroid function and insulin secretion from the perfused pancreas in the rat</article-title><source>Endocrinology</source><volume>99</volume><fpage>125</fpage><year>1976</year></mixed-citation></ref>
<ref id="b2-kjim-2-1-18-3"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malaisse</surname><given-names>WJ</given-names></name><name><surname>Malaisse-Lagae</surname><given-names>F</given-names></name><name><surname>McGraw</surname><given-names>EF</given-names></name></person-group><article-title>Effect of thyroid function upon insulin secretion</article-title><source>Diabetes</source><volume>16</volume><fpage>643</fpage><year>1967</year></mixed-citation></ref>
<ref id="b3-kjim-2-1-18-3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okajima</surname><given-names>F</given-names></name><name><surname>Ui</surname><given-names>M</given-names></name></person-group><article-title>Adrenergic modulation of insulin secretion in vivo dependent on thyroid states</article-title><source>Am J Physiol</source><volume>235</volume><fpage>E106</fpage><year>1978</year></mixed-citation></ref>
<ref id="b4-kjim-2-1-18-3"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>O</given-names></name><name><surname>Friis</surname><given-names>T</given-names></name><name><surname>Ottesen</surname><given-names>B</given-names></name></person-group><article-title>Glucose tolerance and insulin secretion in hyperthyroidism</article-title><source>Acta Endocrinol</source><volume>84</volume><fpage>576</fpage><year>1977</year></mixed-citation></ref>
<ref id="b5-kjim-2-1-18-3"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahn</surname><given-names>CR</given-names></name></person-group><article-title>Membrane receptors for hormones and neurotransmitters</article-title><source>J Cell Biol</source><volume>70</volume><fpage>261</fpage><year>1976</year></mixed-citation></ref>
<ref id="b6-kjim-2-1-18-3"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caro</surname><given-names>JF</given-names></name><name><surname>Amatruda</surname><given-names>JM</given-names></name></person-group><article-title>Insulin receptors in hepatocytes; Prospective events mediate down regulation</article-title><source>Science</source><volume>210</volume><fpage>1029</fpage><year>1980</year></mixed-citation></ref>
<ref id="b7-kjim-2-1-18-3"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olefsky</surname><given-names>JM</given-names></name></person-group><article-title>Insulin resistance and insulin action; An in vitro and in vivo perspective</article-title><source>Diabetes</source><volume>30</volume><fpage>148</fpage><year>1980</year></mixed-citation></ref>
<ref id="b8-kjim-2-1-18-3"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedersen</surname><given-names>O</given-names></name><name><surname>Hjollund</surname><given-names>E</given-names></name></person-group><article-title>Insulin receptor binding to fat and blood cells and insulin action in fat cells from insulin-dependent diabetics</article-title><source>Diabetes</source><volume>31</volume><fpage>706</fpage><year>1982</year></mixed-citation></ref>
<ref id="b9-kjim-2-1-18-3"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garvey</surname><given-names>WT</given-names></name><name><surname>Olefsky</surname><given-names>JM</given-names></name><name><surname>Griffin</surname><given-names>J</given-names></name><name><surname>Hamman</surname><given-names>RF</given-names></name><name><surname>Kolterman</surname><given-names>OG</given-names></name></person-group><article-title>The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus</article-title><source>Diabetes</source><volume>34</volume><fpage>222</fpage><year>1985</year></mixed-citation></ref>
<ref id="b10-kjim-2-1-18-3"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laker</surname><given-names>ME</given-names></name><name><surname>Mayes</surname><given-names>PA</given-names></name></person-group><article-title>Effect of hyperthyroidism and hypothyroidism on lipid and carbohydrate metabolism of the perfused rat liver</article-title><source>Biochem J</source><volume>196</volume><fpage>247</fpage><year>1981</year></mixed-citation></ref>
<ref id="b11-kjim-2-1-18-3"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahren</surname><given-names>B</given-names></name><name><surname>Lundquist</surname><given-names>I</given-names></name></person-group><article-title>Insulin secretory response to different secretagogues in hyper- and hypothyroid mice</article-title><source>Acta Endocrinol</source><volume>97</volume><fpage>508</fpage><year>1964</year></mixed-citation></ref>
<ref id="b12-kjim-2-1-18-3"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodbell</surname><given-names>M</given-names></name></person-group><article-title>Metabolism of isolated fat cells: Effects of hormones in glucose metabolism and lipolysis</article-title><source>J Biol Chem</source><volume>239</volume><fpage>375</fpage><year>1964</year></mixed-citation></ref>
<ref id="b13-kjim-2-1-18-3"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gliemann</surname><given-names>J</given-names></name></person-group><article-title>Assay of insulin-like activity by the isolated fat cell method</article-title><source>Diabetologia</source><volume>3</volume><fpage>382</fpage><year>1967</year></mixed-citation><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gliemann</surname><given-names>J</given-names></name><name><surname>Gammeltoft</surname><given-names>S</given-names></name><name><surname>Vinten</surname><given-names>J</given-names></name></person-group><article-title>Insulin receptors in fat cells; Relationship between binding and activation</article-title><source>Israel J Med Sci</source><volume>11</volume><fpage>656</fpage><year>1975</year></mixed-citation></ref>
<ref id="b14-kjim-2-1-18-3"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moody</surname><given-names>AJ</given-names></name><name><surname>Stan</surname><given-names>MA</given-names></name><name><surname>Stan</surname><given-names>M</given-names></name><name><surname>Gliemann</surname><given-names>J</given-names></name></person-group><article-title>A simple free fat cell bioassay for insulin-like activity</article-title><source>Horm Metab Re</source><volume>6</volume><fpage>12</fpage><year>1974</year></mixed-citation></ref>
<ref id="b15-kjim-2-1-18-3"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scatchard</surname><given-names>G</given-names></name></person-group><article-title>The attractions of proteins for small molecules and ions</article-title><source>Ann N Y Acad Sci</source><volume>51</volume><fpage>660</fpage><year>1949</year></mixed-citation></ref>
<ref id="b16-kjim-2-1-18-3"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeMeyts</surname><given-names>P</given-names></name><name><surname>Roth</surname><given-names>J</given-names></name></person-group><article-title>Cooperativity in ligand binding; A new graphic analysis</article-title><source>Biochem Biophys Res Commun</source><volume>66</volume><fpage>1118</fpage><year>1975</year></mixed-citation></ref>
<ref id="b17-kjim-2-1-18-3"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamberg</surname><given-names>BA</given-names></name></person-group><article-title>Glucose metabolism in thyroid disease</article-title><source>Acta Med Scand</source><volume>178</volume><fpage>351</fpage><year>1975</year></mixed-citation></ref>
<ref id="b18-kjim-2-1-18-3"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000F6;ttger</surname><given-names>I</given-names></name><name><surname>Kriegel</surname><given-names>H</given-names></name><name><surname>Wieland</surname><given-names>O</given-names></name></person-group><article-title>Fluctuation of hepatic enzymes important in glucose metabolism in relation to thyroid function</article-title><source>Eur J Biochem</source><volume>13</volume><fpage>253</fpage><year>1970</year></mixed-citation></ref>
<ref id="b19-kjim-2-1-18-3"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hales</surname><given-names>CN</given-names></name><name><surname>Hyam</surname><given-names>DE</given-names></name></person-group><article-title>Plasma concentrations of glucose, non-esterified fatty acid and insulin during oral glucose tolerance tests in thyrotoxicosis</article-title><source>Lancet</source><volume>2</volume><fpage>69</fpage><comment>11964</comment></mixed-citation></ref>
<ref id="b20-kjim-2-1-18-3"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nilson</surname><given-names>OR</given-names></name><name><surname>Kagedal</surname><given-names>B</given-names></name><name><surname>Tegler</surname><given-names>L</given-names></name></person-group><article-title>Insulin release and carbohydrate tolerance in hyperthyroid patient during non-selective or selective B-adrenoreceptor blockade</article-title><source>Acta Endocrinol</source><volume>93</volume><fpage>179</fpage><year>1980</year></mixed-citation></ref>
<ref id="b21-kjim-2-1-18-3"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renauld</surname><given-names>A</given-names></name><name><surname>Pinto</surname><given-names>JEB</given-names></name><name><surname>Sverdlik</surname><given-names>RC</given-names></name><name><surname>Foglia</surname><given-names>VG</given-names></name></person-group><article-title>Studies on the effect of hyperthyroidism on the insulin response to hyperglycemia in the dog</article-title><source>Horm Metab Res</source><volume>3</volume><fpage>247</fpage><year>1971</year></mixed-citation></ref>
<ref id="b22-kjim-2-1-18-3"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavagnini</surname><given-names>F</given-names></name><name><surname>Peracchi</surname><given-names>M</given-names></name><name><surname>Raggi</surname><given-names>U</given-names></name><name><surname>Sana</surname><given-names>R</given-names></name><name><surname>Pontiroli</surname><given-names>AE</given-names></name><name><surname>Malinverni</surname><given-names>A</given-names></name><name><surname>Pinto</surname><given-names>M</given-names></name></person-group><article-title>Impairment of growth hormone and insulin secretion in hyperthyroidism</article-title><source>Eur J Clin Invest</source><volume>4</volume><fpage>71</fpage><year>1974</year></mixed-citation></ref>
<ref id="b23-kjim-2-1-18-3"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenzen</surname><given-names>S</given-names></name></person-group><article-title>Dose response studies on the inhibitory effect of thyroid hormones on insulin secretion in the rat</article-title><source>Metabolism</source><volume>27</volume><fpage>81</fpage><year>1978</year></mixed-citation></ref>
<ref id="b24-kjim-2-1-18-3"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renauld</surname><given-names>A</given-names></name><name><surname>Sverdlik</surname><given-names>RC</given-names></name><name><surname>Rodriques</surname><given-names>RR</given-names></name></person-group><article-title>Metabolism and endocrine effects of longterm thyroxine treatment</article-title><source>Horm Metab Rbs</source><volume>10</volume><fpage>568</fpage><year>1978</year></mixed-citation></ref>
<ref id="b25-kjim-2-1-18-3"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wajchenberg</surname><given-names>BL</given-names></name><name><surname>Cesar</surname><given-names>FP</given-names></name><name><surname>Leme</surname><given-names>CE</given-names></name><name><surname>Souza</surname><given-names>IT</given-names></name><name><surname>Pieroni</surname><given-names>RR</given-names></name><name><surname>Mattar</surname><given-names>E</given-names></name></person-group><article-title>Effects of adrenergic stimulating and blocking agents on glucose-induced insulin response in human thyrotoxicosis</article-title><source>Metabolism</source><volume>27</volume><fpage>1715</fpage><year>1978</year></mixed-citation></ref>
<ref id="b26-kjim-2-1-18-3"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olefsky</surname><given-names>J</given-names></name><name><surname>Reaven</surname><given-names>GM</given-names></name></person-group><article-title>The human lymphocyte; A model for the study of insulin-receptor interaction</article-title><source>J Clin Endocrinol Metab</source><volume>38</volume><fpage>554</fpage><year>1973</year></mixed-citation></ref>
<ref id="b27-kjim-2-1-18-3"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gambhir</surname><given-names>KK</given-names></name><name><surname>Archer</surname><given-names>JA</given-names></name><name><surname>Carter</surname><given-names>L</given-names></name></person-group><article-title>Insulin radioreceptor assay for human erythrocytes</article-title><source>Clin Chem</source><volume>23</volume><fpage>1590</fpage><year>1977</year></mixed-citation></ref>
<ref id="b28-kjim-2-1-18-3"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pillet</surname><given-names>RJ</given-names></name><name><surname>Standaert</surname><given-names>ML</given-names></name><name><surname>Haase</surname><given-names>BA</given-names></name></person-group><article-title>Insulin binding to the human lymphocyte receptor</article-title><source>J Biol Chem</source><volume>252</volume><fpage>5828</fpage><year>1977</year></mixed-citation></ref>
<ref id="b29-kjim-2-1-18-3"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kappy</surname><given-names>MS</given-names></name><name><surname>Plotnick</surname><given-names>L</given-names></name></person-group><article-title>Studies of insulin binding in children using human erythrocytes in small amounts of blood</article-title><source>Diabetes</source><volume>28</volume><fpage>1001</fpage><year>1979</year></mixed-citation></ref>
<ref id="b30-kjim-2-1-18-3"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roabell</surname><given-names>M</given-names></name></person-group><article-title>Metabolism of isolated fat cells: The effects of insulin, lipolytic hormones and theophylline on glucose transport and metabolism in &#x0201C;Ghosta&#x0201D;</article-title><source>J Biol Chem</source><volume>242</volume><fpage>5751</fpage><year>1967</year></mixed-citation></ref>
<ref id="b31-kjim-2-1-18-3"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salans</surname><given-names>LB</given-names></name><name><surname>Sray</surname><given-names>GA</given-names></name><name><surname>Cushman</surname><given-names>SW</given-names></name><name><surname>Danforth</surname><given-names>E</given-names></name><name><surname>Glennon</surname><given-names>JA</given-names></name><name><surname>Horton</surname><given-names>ES</given-names></name><name><surname>Sims</surname><given-names>EAR</given-names></name></person-group><article-title>Glucose metabolism and the response to insulin by human adipose tissue in spontaneous and experimental obesity</article-title><source>J Clin Invest</source><volume>53</volume><fpage>848</fpage><year>1974</year></mixed-citation></ref>
<ref id="b32-kjim-2-1-18-3"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gliemann</surname><given-names>J</given-names></name><name><surname>Gammeltoft</surname><given-names>S</given-names></name><name><surname>Vinten</surname><given-names>J</given-names></name></person-group><article-title>Insulin receptors in fat cells: Relationship between binding and activation</article-title><source>Israel J Med Sci</source><volume>11</volume><fpage>656</fpage><year>1975</year></mixed-citation></ref>
<ref id="b33-kjim-2-1-18-3"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>HL</given-names></name><name><surname>Wisher</surname><given-names>MF</given-names></name><name><surname>Brandenburg</surname><given-names>D</given-names></name><name><surname>Sonksen</surname><given-names>PH</given-names></name></person-group><article-title>Insulin action on adipocytes; Evidence that the antilipolytic and lipogenic effects of insulin are mediated by the same receptor</article-title><source>Biochem J</source><volume>184</volume><fpage>355</fpage><year>1979</year></mixed-citation></ref>
<ref id="b34-kjim-2-1-18-3"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arner</surname><given-names>P</given-names></name><name><surname>Bolincler</surname><given-names>J</given-names></name><name><surname>Wennlund</surname><given-names>A</given-names></name><name><surname>Ostman</surname><given-names>J</given-names></name></person-group><article-title>Influence of thyroid hormone level on insulin action in human adipose tissue</article-title><source>Diabetes</source><volume>33</volume><fpage>369</fpage><year>1984</year></mixed-citation></ref>
<ref id="b35-kjim-2-1-18-3"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heise</surname><given-names>R</given-names></name><name><surname>Jooster</surname><given-names>HG</given-names></name><name><surname>Hasselblatt</surname><given-names>A</given-names></name></person-group><article-title>Insulin binding and response to insulin of adipocytes from thyroxine treated rats</article-title><source>Endocrinology</source><volume>110</volume><fpage>955</fpage><year>1982</year></mixed-citation></ref>
<ref id="b36-kjim-2-1-18-3"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeRuyter</surname><given-names>H</given-names></name><name><surname>Burman</surname><given-names>KD</given-names></name><name><surname>Wartofsky</surname><given-names>L</given-names></name><name><surname>Taylor</surname><given-names>SI</given-names></name></person-group><article-title>Effects of thyroid hormone on the insulin receptor in rat liver membranes</article-title><source>Endocrinology</source><volume>110</volume><fpage>1922</fpage><year>1982</year></mixed-citation></ref>
<ref id="b37-kjim-2-1-18-3"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavin</surname><given-names>JR</given-names><suffix>III</suffix></name><name><surname>Roth</surname><given-names>J</given-names></name><name><surname>Neville</surname><given-names>DM</given-names></name><name><surname>DeMeyts</surname><given-names>P</given-names></name><name><surname>Buel</surname><given-names>DN</given-names></name></person-group><article-title>Insulin dependent regulation of insulin receptor concentrations. A direct demonstration in cell culture</article-title><source>Proc Natl Acad Sci USA</source><volume>71</volume><fpage>84</fpage><year>1974</year></mixed-citation></ref>
<ref id="b38-kjim-2-1-18-3"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inwegen</surname><given-names>RG</given-names></name><name><surname>Robinson</surname><given-names>GA</given-names></name><name><surname>Thompson</surname><given-names>WJ</given-names></name></person-group><article-title>Cyclic nucleotide phosphodiesterases and thyroid hormones</article-title><source>J Biol Chem</source><volume>250</volume><fpage>2452</fpage><year>1975</year></mixed-citation></ref>
<ref id="b39-kjim-2-1-18-3"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malbeon</surname><given-names>CC</given-names></name><name><surname>Moreno</surname><given-names>FJ</given-names></name><name><surname>Cabelli</surname><given-names>RJ</given-names></name><name><surname>Fain</surname><given-names>JN</given-names></name></person-group><article-title>Fat cell adenylate cyclase and B-adrenergic receptors in altered thyroid states</article-title><source>J Biol Chem</source><volume>253</volume><fpage>671</fpage><year>1975</year></mixed-citation></ref></ref-list>
<sec sec-type="display-objects">
<title>Figures and Tables</title>
<fig id="f1-kjim-2-1-18-3" position="float">
<label>Fig. 1.</label>
<caption>
<p>Competition-inhibition curves. The percent of total radioactivity specifically bound by adipocytes is plotted against total insulin concentrations (ng/ml). Values shown are mean &#x000B1; S. D.</p></caption>
<graphic xlink:href="kjim-2-1-18-3f1.tif"/></fig>
<fig id="f2-kjim-2-1-18-3" position="float">
<label>Fig. 2.</label>
<caption>
<p>Scatchard plot. Percent bound-to-free insulin is plotted against total insulin bound to adipocytes specifically for the insulin concentrations from 0.1&#x02013;100mg/ml. The receptor concentrations of each groups are the X-intercept of each curve.</p></caption>
<graphic xlink:href="kjim-2-1-18-3f2.tif"/></fig>
<fig id="f3-kjim-2-1-18-3" position="float">
<label>Fig. 3.</label>
<caption>
<p>The average affinities (K&#x00304;) were plotted against the log of the percent occupancy of the receptors (log &#x01fe9; &#x0003d; log B/Ro &#x000D7; 100) at each point. The average empty site affinities (K&#x00304;e) were estimated when the value of &#x01fe9; was zero. The average full site affinities (K&#x00304;f) were taken as the nadirs in affinity from the affinity profiles (when &#x01fe9; &#x0003d; 1). Values shown are means.</p></caption>
<graphic xlink:href="kjim-2-1-18-3f3.tif"/></fig>
<fig id="f4-kjim-2-1-18-3" position="float">
<label>Fig. 4.</label>
<caption>
<p>Ability of adipocytes from each groups to convert the glucose to lipid.</p></caption>
<graphic xlink:href="kjim-2-1-18-3f4.tif"/></fig>
<table-wrap id="t1-kjim-2-1-18-3" position="float">
<label>Table 1.</label>
<caption>
<p>Comparison of Serum T<sub>3</sub>, T<sub>4</sub>, Plasma Glucose and Insulin in Control, Hyperthyroid and Hypothyroid Rats</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" valign="middle">Group</th>
<th align="center" valign="middle" rowspan="2">Control (n &#x0003D; 15) M &#x000B1; SD</th>
<th align="center" valign="middle" rowspan="2">Hyperthyroid (n&#x0003D;15) M &#x000B1; SD</th>
<th align="center" valign="middle" rowspan="2">Hyperthyroid (n&#x0003D;15) M &#x000B1; SD</th></tr>
<tr>
<th align="left" valign="middle">Component in serum</th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top">T<sub>3</sub> (ng/ml)</td>
<td align="center" valign="top">1.2&#x000B1;0.2</td>
<td align="center" valign="top">2.4 &#x000B1; 0.4<sup><xref ref-type="table-fn" rid="tfn1-kjim-2-1-18-3">&#x0002A;</xref></sup></td>
<td align="center" valign="top">0.4 &#x000B1;0.1<sup><xref ref-type="table-fn" rid="tfn1-kjim-2-1-18-3">&#x0002A;</xref></sup></td></tr>
<tr>
<td align="left" valign="top">T<sub>4</sub> (ug/dl)</td>
<td align="center" valign="top">5.2 &#x000B1; 0.7</td>
<td align="center" valign="top">12.1 &#x000B1;2.3<sup><xref ref-type="table-fn" rid="tfn1-kjim-2-1-18-3">&#x0002A;</xref></sup></td>
<td align="center" valign="top">1.4 &#x000B1; 0.3<sup><xref ref-type="table-fn" rid="tfn1-kjim-2-1-18-3">&#x0002A;</xref></sup></td></tr>
<tr>
<td align="left" valign="top">Glucose (mg/dl)</td>
<td align="center" valign="top">148.2 &#x000B1; 13.2</td>
<td align="center" valign="top">147.0 &#x000B1; 12.5</td>
<td align="center" valign="top">164.9 &#x000B1; 12.0<sup><xref ref-type="table-fn" rid="tfn1-kjim-2-1-18-3">&#x0002A;</xref></sup></td></tr>
<tr>
<td align="left" valign="top">Insulin (uU/ml)</td>
<td align="center" valign="top">23.1 &#x000B1; 11</td>
<td align="center" valign="top">21.6 &#x000B1; 3.7</td>
<td align="center" valign="top">20.5 &#x000B1; 7.0</td></tr></tbody></table>
<table-wrap-foot><fn id="tfn1-kjim-2-1-18-3">
<label>&#x0002A;</label>
<p>P&#x0003C;.005 versus control</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="t2-kjim-2-1-18-3" position="float">
<label>Table 2.</label>
<caption>
<p><sup>125</sup>I-Insulin Binding to Adipocytes of Rats</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top" rowspan="2"/>
<th align="center" valign="top" rowspan="2">Maximal specific <sup>125</sup>I-Insulin bound (&#x00025;)</th>
<th colspan="2" align="center" valign="top">Receptor concentration
<hr/></th>
<th colspan="2" align="center" valign="top">Receptor affinity (K&#x00304; &#x000D7; 10<sup>7</sup>/M)</th></tr>
<tr>
<th align="center" valign="top">ng/0.5 &#x000D7; 10<sup>5</sup> cells</th>
<th align="center" valign="top">binding site &#x000D7; 10<sup>6</sup> / cell</th>
<th align="center" valign="top">K&#x00304;e</th>
<th align="center" valign="top">K&#x00304;f</th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top">Control</td>
<td align="center" valign="top">1.36 &#x000B1; 0.07</td>
<td align="center" valign="top">0.72 &#x000B1; 0.01</td>
<td align="center" valign="top">1.51</td>
<td align="center" valign="top">8.09</td>
<td align="center" valign="top">2.74</td></tr>
<tr>
<td align="left" valign="top">Hyperthyroid group</td>
<td align="center" valign="top">1.37 &#x000B1; 0.08</td>
<td align="center" valign="top">0.79 &#x000B1; 0.02</td>
<td align="center" valign="top">1.66</td>
<td align="center" valign="top">7.11</td>
<td align="center" valign="top">2.55</td></tr>
<tr>
<td align="left" valign="top">Hypothyroid group</td>
<td align="center" valign="top">1.42 &#x000B1; 0.04<xref ref-type="table-fn" rid="tfn4-kjim-2-1-18-3"><sup>&#x0002A;</sup></xref></td>
<td align="center" valign="top">1.09 &#x000B1; 0.02<xref ref-type="table-fn" rid="tfn5-kjim-2-1-18-3"><sup>&#x0002A;&#x0002A;</sup></xref></td>
<td align="center" valign="top">2.29<xref ref-type="table-fn" rid="tfn5-kjim-2-1-18-3"><sup>&#x0002A;&#x0002A;</sup></xref></td>
<td align="center" valign="top">8.07</td>
<td align="center" valign="top">3.76</td></tr></tbody></table>
<table-wrap-foot><fn id="tfn2-kjim-2-1-18-3">
<p>K&#x00304;e : The average empty site affinities</p></fn><fn id="tfn3-kjim-2-1-18-3">
<p>K&#x00304;f : The average full site affinities</p></fn><fn id="tfn4-kjim-2-1-18-3">
<label>&#x0002A;</label>
<p>P &#x0003C; .05,</p></fn><fn id="tfn5-kjim-2-1-18-3">
<label>&#x0002A;&#x0002A;</label>
<p>P&#x0003C;.005, versus control</p></fn></table-wrap-foot></table-wrap></sec></back></article>
